Tone F Bathen Selected Research

Docetaxel (Taxotere)

2/2018	APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.
4/2015	Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.
1/2010	Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tone F Bathen Research Topics

Disease

45	Neoplasms (Cancer) 06/2022 - 02/2006
33	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
18	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 03/2016
3	Neoplasm Metastasis (Metastasis) 10/2015 - 07/2007
3	Colonic Neoplasms (Colon Cancer) 07/2010 - 11/2007
2	Inflammation (Inflammations) 01/2020 - 10/2018
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2019 - 10/2017
2	7 Hereditary Prostate Cancer 10/2017 - 01/2013
2	Triple Negative Breast Neoplasms 01/2017 - 12/2014
2	Pre-Eclampsia (Preeclampsia) 11/2015 - 09/2015
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 11/2015 - 09/2015
2	Hypoxia (Hypoxemia) 10/2015 - 05/2012
2	Carcinoma (Carcinomatosis) 09/2013 - 01/2013
2	Necrosis 02/2013 - 01/2013
2	Brain Neoplasms (Brain Tumor) 01/2013 - 07/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Heart Failure 04/2020
1	Myocardial Infarction 04/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Weight Gain 10/2018
1	Endometrial Neoplasms (Endometrial Cancer) 04/2018
1	Adenocarcinoma 02/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2010
15	Choline (Choline Chloride)IBA 04/2018 - 02/2006
11	LipidsIBA 01/2022 - 01/2007
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2006
9	Protons (Proton)IBA 04/2018 - 01/2007
9	Lactic Acid (Lactate)FDA LinkGeneric 10/2015 - 01/2007
7	Citric Acid (Citrate)FDA LinkGeneric 06/2022 - 01/2013
7	Phenobarbital (Luminal)FDA Link 01/2019 - 11/2010
6	CreatineIBA 04/2018 - 02/2006
5	SpermineIBA 06/2022 - 01/2013
5	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2014 - 02/2006
4	Lipoproteins (Lipoprotein)IBA 01/2022 - 03/2016
4	Taurine FDA Link 01/2021 - 02/2006
4	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2018
4	Phosphorylcholine (Phosphocholine)IBA 01/2016 - 07/2010
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016 - 06/2014
3	ZincIBA 06/2022 - 01/2020
3	Hormones (Hormone)IBA 11/2019 - 08/2007
3	Docetaxel (Taxotere)FDA Link 02/2018 - 01/2010
2	Peptides (Polypeptides)IBA 01/2022 - 02/2018
2	Aspartic Acid (Aspartate)FDA Link 01/2021 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 11/2007
2	CytokinesIBA 01/2020 - 11/2015
2	Pharmaceutical PreparationsIBA 10/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	Biological ProductsIBA 04/2018 - 01/2016
2	CholesterolIBA 01/2018 - 03/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2016 - 02/2010
2	Estrogen ReceptorsIBA 03/2016 - 11/2012
2	NitrogenIBA 01/2016 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 05/2012
2	phosphorylethanolamine (phosphoethanolamine)IBA 09/2014 - 06/2014
2	Alanine (L-Alanine)FDA Link 09/2013 - 11/2010
2	Inositol (Myoinositol)IBA 07/2010 - 02/2006
1	MetallothioneinIBA 06/2022
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021
1	AntioxidantsIBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 04/2020
1	Oxygen (Dioxygen)IBA 04/2020
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	CollagenIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2019
1	ProteomeIBA 01/2019
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2019
1	Cell-Penetrating PeptidesIBA 02/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2018
1	GadoliniumIBA 01/2018
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2018
1	WD repeat containing planar cell polarity effectorIBA 10/2017
1	Amino Acids FDA Link 05/2017
1	Everolimus FDA Link 01/2017
1	Contrast MediaIBA 11/2016
1	RotenoneIBA 03/2016
1	Metformin (Glucophage)FDA LinkGeneric 03/2016
1	O-GlcNAc transferaseIBA 03/2016
1	HDL LipoproteinsIBA 03/2016
1	LDL CholesterolIBA 03/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2016
1	HDL CholesterolIBA 03/2016

Therapy/Procedure

11	Neoadjuvant Therapy 01/2022 - 06/2009
6	Prostatectomy (Retropubic Prostatectomy) 01/2018 - 01/2013
4	Therapeutics 01/2020 - 07/2007
4	Drug Therapy (Chemotherapy) 10/2018 - 06/2009
3	Aftercare (After-Treatment) 01/2018 - 07/2007
2	Radiotherapy 01/2022 - 07/2007
1	Combined Modality Therapy 01/2022
1	Lasers (Laser) 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 04/2017
1	PET protocol 04/2017